JAZZ | Jazz Pharmaceuticals plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31
Revenue	3.83B	3.66B	3.09B	2.36B	2.16B	1.89B	1.62B	1.49B	1.32B	1.17B	872.40M	586.00M	272.30M	173.70M	128.40M	67.50M	65.30M	44.86M	21.44M	N/A
Cost of Revenue	1.04B	540.52M	440.76M	148.92M	127.93M	121.54M	110.19M	105.39M	102.53M	117.42M	102.10M	78.40M	13.90M	13.60M	9.60M	13.90M	8.90M	6.97M	4.29M	N/A
Gross Profit	2.79B	3.12B	2.65B	2.21B	2.03B	1.77B	1.51B	1.38B	1.22B	1.06B	770.30M	507.60M	258.40M	160.10M	118.80M	53.60M	56.40M	37.89M	17.15M	N/A
Operating Expenses	2.13B	2.61B	2.48B	1.45B	1.39B	1.11B	894.66M	767.18M	682.53M	617.88M	429.96M	309.71M	130.50M	102.43M	102.88M	194.19M	195.18M	115.94M	74.29M	N/A
Selling, General & Admin	1.28B	1.42B	1.45B	854.23M	736.94M	683.53M	544.16M	502.89M	449.12M	406.11M	304.30M	223.88M	108.94M	69.00M	58.65M	111.40M	78.54M	51.38M	23.55M	N/A
Research & Development	849.66M	590.45M	505.75M	335.38M	299.73M	226.62M	198.44M	186.05M	135.25M	287.81M	46.60M	20.50M	14.10M	25.60M	36.60M	70.00M	69.80M	54.96M	45.78M	N/A
Other Operating Expenses	1.48B	599.17M	525.77M	259.58M	354.81M	201.50M	152.06M	78.24M	98.16M	-76.04M	79.06M	65.33M	7.47M	7.84M	7.63M	12.79M	46.84M	9.60M	4.96M	N/A
Operating Income	659.28M	512.27M	170.28M	765.46M	532.37M	614.84M	528.84M	591.02M	491.40M	195.59M	336.60M	197.80M	126.60M	45.50M	15.90M	-170.40M	-138.80M	-78.05M	-57.14M	N/A
Other Expenses / Income	-361.35M	-885.05M	-283.12M	-490.37M	-78.07M	-51.20M	-87.72M	-58.95M	-55.47M	-44.03M	-28.60M	-20.40M	-1.60M	-12.70M	-22.70M	-13.90M	N/A	30.48M	-22.20M	N/A
Before Tax Income	297.93M	-372.78M	-112.84M	275.10M	454.30M	529.46M	441.12M	532.07M	435.93M	151.56M	308.00M	177.40M	125.00M	32.80M	-6.80M	-184.30M	-138.80M	N/A	N/A	N/A
Income Tax Expenses	-119.91M	-158.65M	216.12M	33.52M	-73.15M	80.16M	-47.74M	135.24M	106.40M	94.23M	91.60M	-83.80M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	414.83M	-214.14M	-328.95M	238.62M	523.37M	447.10M	487.85M	396.83M	329.54M	58.39M	216.30M	288.60M	125.00M	32.80M	-6.80M	-184.30M	-138.80M	-59.39M	-85.16M	-24.80M
Interest Expenses	351.12M	288.24M	278.77M	99.71M	72.26M	77.08M	77.76M	61.94M	56.92M	52.71M	26.92M	16.87M	1.68M	12.73M	22.80M	19.74M	N/A	N/A	N/A	N/A
Basic Shares Outstanding	63.29M	62.54M	59.69M	55.71M	56.75M	59.98M	60.02M	61.87M	63.04M	62.61M	61.60M	60.20M	46.80M	39.40M	30.00M	25.60M	13.80M	13.47M	13.47M	13.47M
Diluted Shares Outstanding	72.07M	62.54M	59.69M	56.52M	57.55M	61.22M	61.32M	61.87M	63.04M	62.61M	61.60M	60.20M	46.80M	39.40M	30.00M	25.60M	13.80M	13.47M	13.47M	13.47M
EBITDA	1.30B	1.11B	696.05M	1.03B	997.16M	859.23M	683.02M	707.79M	600.91M	339.01M	416.91M	295.90M	134.50M	54.24M	25.09M	-149.53M	-128.27M	-49.08M	-79.72M	N/A
EBITDA Margin	33.85%	30.37%	22.49%	43.37%	46.13%	45.44%	42.20%	47.57%	45.36%	28.90%	47.79%	50.49%	49.39%	31.23%	19.54%	-221.53%	-196.44%	-109.42%	-371.78%	0.00%
EBIT	646.03M	-84.54M	165.93M	371.84M	522.47M	604.34M	517.86M	594.01M	492.85M	205.33M	334.82M	221.67M	126.67M	45.53M	16.00M	-164.56M	-138.80M	-59.39M	-85.16M	-24.80M
EBIT Margin	16.85%	-2.31%	5.36%	15.73%	24.17%	31.96%	31.99%	39.92%	37.20%	17.51%	38.38%	37.83%	46.52%	26.21%	12.46%	-243.79%	-212.56%	-132.40%	-397.15%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31